These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 18090697)

  • 1. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
    Rasmussen KG; Knapp RG; Biggs MM; Smith GE; Rummans TA; Petrides G; Husain MM; O'Connor MK; Fink M; Kellner CH
    J ECT; 2007 Dec; 23(4):244-50. PubMed ID: 18090697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study.
    Smith GE; Rasmussen KG; Cullum CM; Felmlee-Devine MD; Petrides G; Rummans TA; Husain MM; Mueller M; Bernstein HJ; Knapp RG; O'Connor MK; Fink M; Sampson S; Bailine SH; Kellner CH;
    J Clin Psychiatry; 2010 Feb; 71(2):185-93. PubMed ID: 20193646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment.
    Tew JD; Mulsant BH; Haskett RF; Joan P; Begley AE; Sackeim HA
    Ann Clin Psychiatry; 2007; 19(1):1-4. PubMed ID: 17453654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study.
    Navarro V; Gastó C; Torres X; Masana G; Penadés R; Guarch J; Vázquez M; Serra M; Pujol N; Pintor L; Catalán R
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):498-505. PubMed ID: 18515694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis].
    Rehor G; Conca A; Schlotter W; Vonthein R; Bork S; Bode R; Hüll M; Plewnia C; Di Pauli J; Prapotnik M; Peters O; Peters J; Eschweiler GW
    Neuropsychiatr; 2009; 23(3):157-63. PubMed ID: 19703381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.
    van Beusekom BS; van den Broek WW; Birkenhäger TK
    J ECT; 2007 Mar; 23(1):17-20. PubMed ID: 17435567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation electroconvulsive therapy with pharmacotherapy versus pharmacotherapy alone for prevention of relapse of depression: a randomized controlled trial.
    Nordenskjöld A; von Knorring L; Ljung T; Carlborg A; Brus O; Engström I
    J ECT; 2013 Jun; 29(2):86-92. PubMed ID: 23303421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in a clinical trial of ECT followed by continuation pharmacotherapy: effects immediately after ECT and at 24 weeks.
    McCall WV; Rosenquist PB; Kimball J; Haskett R; Isenberg K; Prudic J; Lasater B; Sackeim HA
    J ECT; 2011 Jun; 27(2):97-102. PubMed ID: 21206285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
    Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
    Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE).
    Kellner CH; Knapp RG; Petrides G; Rummans TA; Husain MM; Rasmussen K; Mueller M; Bernstein HJ; O'Connor K; Smith G; Biggs M; Bailine SH; Malur C; Yim E; McClintock S; Sampson S; Fink M
    Arch Gen Psychiatry; 2006 Dec; 63(12):1337-44. PubMed ID: 17146008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy and cognitive side effects of bifrontal versus right unilateral electroconvulsive therapy (ECT): a short-term randomised controlled trial in pharmaco-resistant major depression.
    Eschweiler GW; Vonthein R; Bode R; Huell M; Conca A; Peters O; Mende-Lechler S; Peters J; Klecha D; Prapotnik M; DiPauli J; Wild B; Plewnia C; Bartels M; Schlotter W
    J Affect Disord; 2007 Aug; 101(1-3):149-57. PubMed ID: 17196664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
    Fink M; Rush AJ; Knapp R; Rasmussen K; Mueller M; Rummans TA; O'Connor K; Husain M; Biggs M; Bailine S; Kellner CH;
    J ECT; 2007 Sep; 23(3):139-46. PubMed ID: 17804986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).
    Rasmussen KG; Mueller M; Rummans TA; Husain MM; Petrides G; Knapp RG; Fink M; Sampson SM; Bailine SH; Kellner CH
    J Clin Psychiatry; 2009 Feb; 70(2):232-7. PubMed ID: 19192459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
    Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
    J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehospitalization rate after continued electroconvulsive therapy--a retrospective chart review of patients with severe depression.
    Nordenskjöld A; von Knorring L; Engström I
    Nord J Psychiatry; 2011 Feb; 65(1):26-31. PubMed ID: 20482461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuation ECT].
    Sartorius A; Henn FA
    Psychiatr Prax; 2005 Nov; 32(8):408-11. PubMed ID: 16308805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term weekly continuation electroconvulsive therapy: a case series.
    Zisselman MH; Rosenquist PB; Curlik SM
    J ECT; 2007 Dec; 23(4):274-7. PubMed ID: 18090702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.